Cargando…
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
BACKGROUND: Interleukin-6 (IL-6) was proposed to be associated with the severity of coronavirus disease 2019 (COVID-19). The present study aimed to explore the kinetics of IL-6 levels, validate this association in COVID-19 patients, and report preliminary data on the efficacy of IL-6 receptor blocka...
Autores principales: | Zhang, Jing, Hao, Yiqun, Ou, Wuling, Ming, Fei, Liang, Gai, Qian, Yu, Cai, Qian, Dong, Shuang, Hu, Sheng, Wang, Weida, Wei, Shaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594951/ https://www.ncbi.nlm.nih.gov/pubmed/33121497 http://dx.doi.org/10.1186/s12967-020-02571-x |
Ejemplares similares
-
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2
por: Dong, Shuang, et al.
Publicado: (2020) -
CompTIA A+ 220-901 and 220-902
por: Prowse, David L
Publicado: (2016) -
Hemilaminectomy for the removal of the spinal tumors: An analysis of 901 patients
por: Liao, Dengyong, et al.
Publicado: (2023) -
Association between serum neuron-specific enolase, age, overweight, and structural MRI patterns in 901 subjects
por: Hoffmann, Johanna, et al.
Publicado: (2017) -
A single-arm, prospective study of apatinib mesylate plus pemetrexed in patients of advanced non-squamous non-small cell lung cancer after failure of previous chemotherapy
por: Dong, Shuang, et al.
Publicado: (2022)